We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration to Develop Catheterization Lab Integration for Vessel Characterization

By HospiMedica International staff writers
Posted on 22 Oct 2012
Philips Healthcare (Best, the Netherlands) and Infraredx, Inc. More...
(Burlington, MA, USA), a medical device company focused on the diagnosis and management of coronary artery and other vascular diseases, have signed a joint development and collaboration agreement that involves incorporating Infraredx’s true vessel characterization (TVC) imaging system with Philips’ Allura Xper catheterization (cath) lab imaging systems.

This collaboration is intended to enable seamless access to the TVC imaging system with Philips’ Allura X-ray systems. “Philips is the premier provider of X-ray imaging technology for interventional cardiologists and we are pleased to partner with them on developing this integrated solution,” said Don Southard, president and chief executive officer of Infraredx. “Our goal is to offer physicians easier access to the TVC imaging system’s near-infrared spectroscopy and intravascular ultrasound technology for use in determining the true extent of cardiovascular disease, especially the presence of lipid core plaques [LCPs]. The imaging system is experiencing accelerated adoption in the United States and Europe. We believe this growth is the result of mounting clinical evidence around the role of LCP and continuous system enhancements.”

The collaboration will provide physicians with tableside control of the TVC imaging system from within the sterile cath lab setting using Allura’s table-mounted Xper module. The TVC composite image can be viewed on the Philips’ cath lab monitors, enabling physicians to view the chemogram and intravascular ultrasound (IVUS) images along with the coronary angiogram. This will allow for better visualization of LCPs in a patient’s coronary artery. The automatic sharing and integration of patient demographics and imaging study information between the Allura system and the TVC system will improve workflow efficiency and provide more rapid retrieval and review of data.

“As the global market leader in cath lab imaging technology, we strive to offer advanced clinical applications that enable interventional procedures to be performed more effectively,” said Bert van Meurs, senior vice president and general manager, interventional X-ray, Philips Healthcare. “The collaboration with Infraredx supports our commitment to continuously improve the integrated functioning of our cath labs and further enhance the user experience.”

The TVC imaging system holds the potential to transform coronary artery disease (CAD) management by providing data that is critical for evaluating vessel structure and composition, also known as true vessel characterization. The system helps interventional cardiologists identify which patients are prone to complications during stenting. The device enables cardiologists to predict periprocedural heart attacks by evaluating not only the level of stenosis, but also the presence and extent of lipid core plaques (LCP) of interest.

The TVC imaging system, in a single pullback, provides rapid and automated detection of LCPs during the cardiac catheterization procedure. The device is the only multimodality imaging system to combine both intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS). Using IVUS technology, the system provides real time information about vessel structure. The system’s enhanced IVUS image provides a clear view of the vessel and plaque, providing more reliable vessel interpretation and assessment.

The system’s NIRS technology enables interventional cardiologists to reliably visualize the presence of LCP and predict the risk of peristenting myocardial infarction. The multimodality images are obtained simultaneously and require no postprocessing or image manipulation.

Infraredx, Inc. is a privately funded medical device company dedicated to helping provide practitioners with the information needed for enhanced clinical decision making in treating coronary artery disease. The company is focused on improving the safety and efficacy of coronary stenting and ultimately serving as part of a strategy to prevent initial coronary events.

Related Links:
Philips Healthcare
Infraredx



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.